← Eichor
Condition: Multiple Myeloma Progression Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Multiple Myeloma Progression

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT03689595Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Phase N/A · 7 location(s) · Dana-Farber Cancer Institute · NCT02269592Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-inten
Phase 2 · 10 location(s) · University of Liege · NCT03852407CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT06644625Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
NA · 1 location(s) · University Health Network, Toronto · NCT06485076Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT06690593Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Phase N/A · 1 location(s) · FengYan Jin · NCT06252792Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07032129Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
EARLY_Phase 1 · 1 location(s) · Oncotherapeutics · NCT06209606A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Phase 4 · 12 location(s) · Johnson & Johnson Private Limited · NCT07030517Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
Phase N/A · 3 location(s) · Tel-Aviv Sourasky Medical Center · NCT05837884Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
Phase 1/Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07109323A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Phase 1 · 10 location(s) · Kelonia Therapeutics, Inc. · NCT07075185
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.